Summary Selecta Biosciences, Inc. (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines to prevent and treat disease. The company's Tolerogenic Synthetic Vaccine Particles (SVP) are designed to induce antigen-specific immune tolerance. Its Tolerogenic SVP products instruct the immune system to prevent and suppress pro-inflammatory responses against a specific antigen. Selecta Biosciences' Stimulatory SVP products are integrated synthetic nanoparticle vaccines and immunotherapies engineered to mimic. The company develops products for the treatment of infections, central nervous system diseases, cancer, allergies, cardiovascular diseases, autoimmunity, metabolic diseases, asthma and acute and chronic inflammatory conditions. Its partners portfolio includes Sanofi, Juvenile Diabetes Research Foundation (JDRF) and Genethon among others. Selecta Biosciences is headquartered in Watertown, Massachusetts, the US. Selecta Biosciences, Inc. Pharmaceuticals & Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The... Research Beam Model: Research Beam Product ID: 663004 250 USD New
Selecta Biosciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Selecta Biosciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Healthcare
  • Published On : May   2016
  • Pages : 34
  • Publisher : GlobalData
 
 
 
Summary

Selecta Biosciences, Inc. (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines to prevent and treat disease. The company's Tolerogenic Synthetic Vaccine Particles (SVP) are designed to induce antigen-specific immune tolerance. Its Tolerogenic SVP products instruct the immune system to prevent and suppress pro-inflammatory responses against a specific antigen. Selecta Biosciences' Stimulatory SVP products are integrated synthetic nanoparticle vaccines and immunotherapies engineered to mimic. The company develops products for the treatment of infections, central nervous system diseases, cancer, allergies, cardiovascular diseases, autoimmunity, metabolic diseases, asthma and acute and chronic inflammatory conditions. Its partners portfolio includes Sanofi, Juvenile Diabetes Research Foundation (JDRF) and Genethon among others. Selecta Biosciences is headquartered in Watertown, Massachusetts, the US.

Selecta Biosciences, Inc. Pharmaceuticals & Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
Business Description A brief description of the company's operations.
Key Employees A list of the key executives of the company.
Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors A list of the key competitors of the company.
Key Recent Developments A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Selecta Biosciences Raises USD38 Million in Series E Financing 11
Selecta Biosciences Raises More than USD20 Million in Venture Financing 13
Selecta Biosciences Raises USD4.4 Million in Venture Financing 15
Selecta Biosciences Raises USD6 Million in Venture Financing 16
Selecta Biosciences Raises USD5.3 Million in Venture Financing 17
Selecta Biosciences Secures US$47 Million In Series D Financing Round 18
Selecta Biosciences Raises US$15 Million In Series C Financing Round 20
Partnerships 22
Selecta Biosciences Enters into Research Agreement with Genethon 22
Selecta Biosciences and Juvenile Diabetes Research Foundation Enter into Co-Development Agreement with Sanofi 23
Juvenile Diabetes Research Foundation Enters Into Research Collaboration With Selecta Biosciences 25
Licensing Agreements 27
Selecta Biosciences Exercises Option for Licensing Agreement with Sanofi 27
Selecta Biosciences Enters into Licensing Agreement with 3SBio for Pegsiticase 28
Selecta Biosciences Enters Into Licensing Agreement With Sanofi To Develop Antigen-Specific Immunotherapies 29
Selecta Biosciences, Inc. - Key Competitors 31
Key Employees 32
Locations And Subsidiaries 33
Head Office 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List Of Tables
List of Tables
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare, Key Facts 1
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Selecta Biosciences, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Selecta Biosciences Raises USD38 Million in Series E Financing 11
Selecta Biosciences Raises More than USD20 Million in Venture Financing 13
Selecta Biosciences Raises USD4.4 Million in Venture Financing 15
Selecta Biosciences Raises USD6 Million in Venture Financing 16
Selecta Biosciences Raises USD5.3 Million in Venture Financing 17
Selecta Biosciences Secures US$47 Million In Series D Financing Round 18
Selecta Biosciences Raises US$15 Million In Series C Financing Round 20
Selecta Biosciences Enters into Research Agreement with Genethon 22
Selecta Biosciences and Juvenile Diabetes Research Foundation Enter into Co-Development Agreement with Sanofi 23
Juvenile Diabetes Research Foundation Enters Into Research Collaboration With Selecta Biosciences 25
Selecta Biosciences Exercises Option for Licensing Agreement with Sanofi 27
Selecta Biosciences Enters into Licensing Agreement with 3SBio for Pegsiticase 28
Selecta Biosciences Enters Into Licensing Agreement With Sanofi To Develop Antigen-Specific Immunotherapies 29
Selecta Biosciences, Inc., Key Competitors 31
Selecta Biosciences, Inc., Key Employees 32

List Of Figures
List of Figures
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Selecta Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter